Single-nucleotide polymorphisms in the sulfatase-modifying factor 1 gene are associated with lung function and COPD

Area of Science:

• Genetics
• Pulmonology
• Biochemistry

Background:

• Single nucleotide polymorphisms (SNPs) are implicated in Chronic Obstructive Pulmonary Disease (COPD) pathogenesis.
• The Sulfatase Modifying Factor 1 (SUMF1) gene plays a role in connective tissue remodeling and has previously shown associations with COPD.

Purpose of the Study:

• To investigate the association between SUMF1 gene SNPs and advanced lung function parameters in COPD patients.

Main Methods:

• Genotyping of 21 SUMF1 SNPs in never-, former-, and current-smokers with or without COPD (n=559).
• Assessment of lung function using spirometry, body plethysmography, diffusing capacity of the lung for carbon monoxide (D_LCO), and impulse oscillometry.

Main Results:

• Four SUMF1 SNPs (rs793391, rs12634248, rs2819590, rs304092) were associated with a decreased odds of COPD and impaired lung function (reduced FEV1/FVC, increased peripheral resistance).
• One SNP (rs3864051) showed a strong association with COPD, reduced FEV1/FVC, FEV1, D_LCO, and impaired lung mechanics.
• Other SUMF1 SNPs (rs4685744, rs2819562, rs2819561, rs11915920) were linked to reduced lung volumes (FVC, TLC, alveolar volume) in individuals with the variant allele.

Conclusions:

• Several SUMF1 gene SNPs are significantly associated with COPD and diminished lung function.
• These genetic variants may contribute to COPD development by disrupting the sulfation balance in lung tissue's extracellular matrix.